12830 EL CAMINO REAL, SAN DIEGO, CA
Board Appointment - Jonathan M. Poole Joins Acadia Pharmaceuticals Board
Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
Acadia Pharmaceuticals Anticipates Over $1 Billion in 2025 Net Sales
Reports Third Quarter 2025 Financial Results and Operating Overview
Director Resignation - Daniel B. Soland Steps Down from Board
Reports Second Quarter 2025 Financial Results and Operating Overview
Other Events
Shareholder votes
FY 2024
Q3
Q2
Q1
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload
S-8 POS